Clinisciences > CD8A Antibody
CD8A Antibody
Marke : Aviva Systems Biology
Weitere Informationen anfordern
Bitte melden Sie sich an, um diese Funktion zu nutzen.
Size:0.1 mg
Bulk
Order
Order
Aviva's
Satisfaction
Guarantee
Satisfaction
Guarantee
Contact Us:
- Toll Free: 888-880-0001
- Phone: 858-552-6979
- Email: info@avivasysbio.com
Shipping Info:
- : Antibody & Protein in US
- + /Kit in US
- Contact us for international orders.
Datasheets/Manuals | Printable datasheet for anti-CD8A (OAEE00997) antibody |
---|
Predicted Species Reactivity | Mouse |
---|---|
Clonality | Monoclonal |
Clone | 53-6.7 |
Isotype | IgG2a |
Host | Rat |
Application | FC, IP, IHC-P, IHC-F, ICC, FN |
Reconstitution and Storage | Store in the dark at 2-8C. Do not freeze. Avoid prolonged exposure to light. Do not use after expiration date stamped on vial label. Short-term exposure to room temperature should not affect the quality of the reagent. However, if reagent is stored under any conditions other than those specified, the conditions must be verified by the user. |
Immunogen | Mouse spleen cells |
Purification | Purified by size-exclusion chromatography |
Concentration | 0.5 mg/ml |
Specificity | The rat monoclonal antibody 53-6.7 recognizes mouse CD8a (32-34 kDa; alpha chain of the CD8 antigen). |
Formulation | PerCP |
Storage Buffer | Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.4 |
Reference | Mochimaru H, Usui T, Yaguchi T, Nagahama Y, Hasegawa G, Usui Y, Shimmura S, Tsubota K, Amano S, Kawakami Y, Ishida S: Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2. Invest Ophthalmol Vis Sci. 2008 May;49(5):2172-7. Bouwer HG, Alberti-Segui C, Montfort MJ, Berkowitz ND, Higgins DE: Directed antigen delivery as a vaccine strategy for an intracellular bacterialpathogen. Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5102-7. Kamimura D, Sawa Y, Sato M, Agung E, Hirano T, Murakami M: IL-2 in vivo activities and antitumor efficacy enhanced by an anti-IL-2 mAb. J Immunol. 2006 Jul 1;177(1):306-14. Ko SY, Ko HJ, Chang WS, Park SH, Kweon MN, Kang CY: alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J Immunol. 2005 Sep 1;175(5):3309-17. Grabbe S, Varga G, Beissert S, Steinert M, Pendl G, Seeliger S, Bloch W, Peters T, Schwarz T, Sunderkötter C, Scharffetter-Kochanek K: Beta2 integrins are required for skin homing of primed T cells but not for priming naive T cells. J Clin Invest. 2002 Jan;109(2):183-92. Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y, Kanai C, Moriizumi E, Nomura T, Nakamura T, Sakaguchi S. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest. 2004 Aug;114(4):582-8. Takahashi K, Nakata M, Tanaka T, Adachi H, Nakauchi H, Yagita H, Okumura K: CD4 and CD8 regulate interleukin 2 responses of T cells. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5557-61. Ledbetter JA, Rouse RV, Micklem HS, Herzenberg LA: T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J Exp Med. 1980 Aug 1;152(2):280-95. Ledbetter JA, Herzenberg LA: Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev. 1979;47:63-90. |
---|---|
Gene Symbol | CD8A |
Gene Full Name | T-cell surface glycoprotein CD8 alpha chain |
Alias Symbols | CD8, p32, Leu2 |
NCBI Gene Id | 925 |
Protein Name | T-cell surface glycoprotein CD8 alpha chain |
Uniprot ID | P01732 |
Protein Accession # | NP_001139345.1; NP_001759.3; NP_741969.1 |
Nucleotide Accession # | NM_001145873.1; NM_001768.6; NM_171827.3 |
Protein interactions
Name | # of Products |
---|---|
B2M | 110 |
CD3D | 100 |
CD59 | 79 |
CD8A | 170 |
CD8B | 44 |
HLA-A | 105 |
HLA-B | 123 |
HLA-C | 93 |
HLA-E | 66 |
HLA-G | 68 |
LAT | 115 |
LCK | 537 |
LGALS1 | 190 |
LNX1 | 98 |
LNX2 | 31 |
PTPRC | 283 |
SREK1 | 122 |
SRSF1 | 99 |
UBC | 7030 |
Biological pathways
Name | # of Products |
---|---|
Antigen processing and presentation | 75 |
Regulation of immune response | 318 |
Transmembrane receptor protein tyrosine kinase signaling pathway | 153 |
Biological process
Name | # of Products |
---|---|
Antigen processing and presentation | 40 |
Cell surface receptor signaling pathway | 179 |
Cytotoxic T cell differentiation | 4 |
Defense response to virus | 72 |
Immune response | 404 |
Positive regulation of calcium-mediated signaling | 36 |
Regulation of immune response | 89 |
T cell activation | 68 |
T cell mediated immunity | 6 |
Transmembrane receptor protein tyrosine kinase signaling pathway | 67 |
Cellular components
Name | # of Products |
---|---|
External side of plasma membrane | 261 |
Extracellular region | 1573 |
Integral to plasma membrane | 817 |
Plasma membrane | 2678 |
T cell receptor complex | 14 |
Protein function
Name | # of Products |
---|---|
Coreceptor activity | 164 |
MHC class I protein binding | 54 |
Protein binding | 12191 |
Protein homodimerization activity | 1852 |
Protein kinase binding | 1101 |
Diseases
Name | # of Products |
---|---|
Disease mutation | 5332 |
- CD8A Antibody - C-terminal region (OAAB01152)Catalog #: OAAB01152Application: FC, IHC-P, WBFormat: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.Size: 400ul
-
- Anti-CD8 (T8) Antibody (OAAI00640)Catalog #: OAAI00640Clone: 3B5Application: ELISA, FC, IHC, IP, WBFormat: Liquid. This affinity purified antibody is supplied in sterile Phosphatebuffered saline (pH7.2) containing antibody stabilizerSize: 100UG
- CD8A ELISA Kit (Human) (OKEH00678)Catalog #: OKEH00678Application: ELISA-SandwichKit Range: 2.81-180ng/mLSensitivity: 1.2 ng/mLSize: 96T
- AvivaBlot Femto ECL Reagent (OKCF00002)Catalog #: OKCF00002Application: WBFormat: LiquidSize: 250 mL